XML 77 R64.htm IDEA: XBRL DOCUMENT v3.19.2
Segment and Geographical Information - Segment Revenue, Operating Income (Loss) and Depreciation and Amortization (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Segment Reporting Information [Line Items]        
Revenue $ 24,344 $ 22,227 $ 69,261 $ 58,298
Operating income (loss) 1,017 (6,250) 2,594 (6,359)
Depreciation and amortization 1,887 1,605 5,462 4,711
Operating Segments [Member]        
Segment Reporting Information [Line Items]        
Revenue 24,344 22,227 69,261 58,298
Operating income (loss) 3,228 (4,017) 8,932 (82)
Operating Segments [Member] | Medical Device [Member]        
Segment Reporting Information [Line Items]        
Revenue 18,945 16,701 53,504 43,527
Operating income (loss) 753 (6,193) 1,087 (6,351)
Depreciation and amortization 1,481 1,333 4,315 3,929
Operating Segments [Member] | In Vitro Diagnostics [Member]        
Segment Reporting Information [Line Items]        
Revenue 5,399 5,526 15,757 14,771
Operating income (loss) 2,475 2,176 7,845 6,269
Depreciation and amortization 120 101 353 291
Corporate [Member]        
Segment Reporting Information [Line Items]        
Operating income (loss) (2,211) (2,233) (6,338) (6,277)
Depreciation and amortization $ 286 $ 171 $ 794 $ 491